SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
🔥 科研通第二届『
应助活动周
』正在进行中,3月24-30日求助秒级响应🚀,千元现金等你拿。
当前排名🏆
📚 中科院2025期刊分区📊 已更新
仁爱的觅夏
Lv4
6
440 积分
2024-12-16 加入
最近求助
最近应助
互助留言
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
1天前
已完结
Long-acting amylin analogues for the management of obesity
1天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
1天前
已完结
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
3天前
已完结
Phase I results for AMG 133
3天前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
9天前
已完结
Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers
11天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
26天前
已完结
Drugging mutant KRAS by disrupting binding to effectors and GTP
1个月前
已完结
Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment
1个月前
已完结
没有进行任何应助
感谢
1天前
感谢
1天前
感谢
2天前
感谢
3天前
感谢
9天前
感谢
11天前
感谢
26天前
感谢
1个月前
感谢
1个月前
谢谢!
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论